Serum Levels of Advanced Oxidation Protein Products and some Liver Function Markers in Chronic Myeloid Leukemia-Chronic Phase Patients Receiving Imatinib or Nilotinib
The treatment of chronic myeloid leukemia has witnessed substantial advancements by the introduction of tyrosine kinase inhibitors. Oxidative stress has been proposed as potential mechanism for resistance to their action. Simultaneously, oxidative stress has a crucial role in hepatic diseases and h...
Tallennettuna:
| Päätekijät: | , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
College of Pharmacy University of Baghdad
2025-06-01
|
| Sarja: | Iraqi Journal of Pharmaceutical Sciences |
| Aiheet: | |
| Linkit: | https://bijps.uobaghdad.edu.iq/index.php/bijps/article/view/2932 |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|